Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Burning Rock Biotech Limited BNR

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal...


Top institutional share ownership of Burning Rock Biotech Limited

Name Shares Shares % change Value Value % change
Massachusetts Financial Services Co /ma/ 4,410,552 76.7% $12,834 -44.7%
Kynam Capital Management, LP 4,300,000 456.2% $12,513 74.2%
ARKG - ARK Genomic Revolution ETF 3,383,088 129.7% $18,641 40.6%
MEMAX - MFS Emerging Markets Equity Fund A 1,888,020 4.3% $4,531 -70.3%
ARK Investment Management LLC 1,772,722 -49.6% $4,255 -87.0%
Vanguard Group Inc 1,654,989 57.1% $4,815 -50.8%
BlackRock Inc. 1,629,523 13.4% $4,742 -64.5%
Orbimed Advisors Llc 1,389,802 -4.3% $4,044 -70.0%
Renaissance Technologies Llc 1,098,200 866.7% $3,196 202.9%
Morgan Stanley 974,196 10.0% $2,834 -65.6%

Top institutional buyers of Burning Rock Biotech Limited

Name Shares % change Value % change Shares Value
Renaissance Technologies Llc 866.7% 202.9% 1,098,200 $3,196
Kynam Capital Management, LP 456.2% 74.2% 4,300,000 $12,513
ARKG - ARK Genomic Revolution ETF 129.7% 40.6% 3,383,088 $18,641
Massachusetts Financial Services Co /ma/ 76.7% -44.7% 4,410,552 $12,834
Vanguard Group Inc 57.1% -50.8% 1,654,989 $4,815
BlackRock Inc. 13.4% -64.5% 1,629,523 $4,742
Morgan Stanley 10.0% -65.6% 974,196 $2,834
VEIEX - Vanguard Emerging Markets Stock Index Fund Investor Shares 6.9% -34.6% 402,315 $2,217
IEMG - iShares Core MSCI Emerging Markets ETF 4.7% -70.2% 439,146 $1,054
MEMAX - MFS Emerging Markets Equity Fund A 4.3% -70.3% 1,888,020 $4,531

Top institutional sellers of Burning Rock Biotech Limited

Name Shares % change Value % change Shares Value
Baillie Gifford & Co -96.2% -98.8% 337,893 $983
Sumitomo Mitsui Trust Holdings, Inc. -64.6% -88.9% 753,004 $2,191
Nikko Asset Management Americas, Inc. -64.6% -89.0% 753,004 $2,199
ARK Investment Management LLC -49.6% -87.0% 1,772,722 $4,255
Price T Rowe Associates Inc /md/ -6.2% -70.6% 329,554 $959
Orbimed Advisors Llc -4.3% -70.0% 1,389,802 $4,044
IBB - iShares Nasdaq Biotechnology ETF -3.2% -69.7% 528,278 $1,537

Information provided by Fintel.io